~~<i id='3426D822F7'><strike id='3426D822F7'><tt id='3426D822F7'><pre id='3426D822F7'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：Wikipedia 2025-09-29 09:59:58 Page View：5

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novo acquires Inversago for up to $1 billion
Next article： In Memoriam: Notable people who died in 2023

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Lilly’s weekly insulin works as well as daily products, new studies show

AdobeEliLillyreportedThursdaythatitsexperimentalweeklyinsulinworkedaswellasdailybasalinsulinproducts

Guidelines to prevent youth baseball injuries need more muscle

Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

1:30Aboywalksthroughafloodedareainal-SagainorthofOmdurmanonAugust6,2023.Torrentialrainshavedestroyed